Novel Dengue Virus NS2B/NS3 Protease Inhibitors

Dengue fever is a severe, widespread, and neglected disease with more than 2 million diagnosed infections per year. The dengue virus NS2B/NS3 protease (PR) represents a prime target for rational drug design. At the moment, there are no clinical PR inhibitors (PIs) available. We have identified diary...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Wu, Hongmei, Bock, Stefanie, Snitko, Mariya, Berger, Thilo, Weidner, Thomas, Holloway, Steven, Kanitz, Manuel, Diederich, Wibke E., Steuber, Holger, Walter, Christof, Hofmann, Daniela, Weißbrich, Benedikt, Spannaus, Ralf, Acosta, Eliana G., Bartenschlager, Ralf, Engels, Bernd, Schirmeister, Tanja, Bodem, Jochen
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2015
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335830/
https://ncbi.nlm.nih.gov/pubmed/25487800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03543-14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares